{"database": "lobbying", "table": "lobbying_activities", "rows": [[632868, "df777223-d31e-424a-ae90-fee6eaf66ddf", "Q2", "AMYLIN PHARMACEUTICALS", 308536, "AMYLIN PHARMACEUTICALS", 2008, "second_quarter", "PHA", "H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics\nH.R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions\nH.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics\nS. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics\nS. 2029, Physician Payments Sunshine Act of 2007\nS. 596 Safe Internet Pharmacy Act of 2007, clinical trials, drug safety provisions\nS. 623, Access to Life-Saving Medicine Act, follow-on biologics\nDrug Importation\nH.R., Pathway for Biosimilars Act\nH.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008", "Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 495000, 0, 0, "2008-07-17T10:47:56-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["632868"], "units": {}, "query_ms": 0.346601998899132, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}